(gustafsson ll or lars l Gustafsson or gustafsson lars L or ((aklillu or mirghani or aalto or
(gustafsson ll or lars l Gustafsson or gustafsson lars L or ((aklillu or mirghani or aalto or
professor i klinisk farmakologi, Karolinska Institutet Stockholm
Verified email at ki.se
Title
Cited by
Cited by
Year
Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden
LL Gustafsson, B Schildt, K Jacobsen
British Journal of Anaesthesia 54 (5), 479-486, 1982
4831982
Present state of extradural and intrathecal opioid analgesia in Sweden: a nationwide follow-up survey
N Rawal, S Arner, LL Gustafsson, R Allvin
British Journal of Anaesthesia 59 (6), 791-799, 1987
2841987
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
J Adamski, B Godman, G Ofierska-Sujkowska, B Osińska, H Herholz, ...
BMC health services research 10 (1), 1-16, 2010
2702010
Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
HG Eichler, E Abadie, A Breckenridge, B Flamion, LL Gustafsson, ...
Nature reviews Drug discovery 10 (7), 495-506, 2011
2672011
Disposition of chloroquine in man after single intravenous and oral doses.
LL Gustafsson, O Walker, G Alvan, B Beermann, F Estevez, L Gleisner, ...
British journal of clinical pharmacology 15 (4), 471-479, 1983
2601983
Identification of human cytochrome P 450 s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
XQ Li, A Björkman, TB Andersson, LL Gustafsson, CM Masimirembwa
European journal of clinical pharmacology 59 (5), 429-442, 2003
2492003
The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm
LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ...
Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011
2332011
Clinical experience of long–term treatment with epidural and intrathecal opioids–a nationwide survey
S Arner, N Rawal, LL Gustafsson
Acta anaesthesiologica Scandinavica 32 (3), 253-259, 1988
2121988
Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants
L Bertilsson, A Åberg-Wistedt, LL Gustafsson, C Nordin
Therapeutic drug monitoring 7 (4), 478-480, 1985
1771985
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010
1742010
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1562009
4β-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians
U Diczfalusy, J Miura, HK Roh, RA Mirghani, J Sayi, H Larsson, KG Bodin, ...
Pharmacogenetics and genomics 18 (3), 201-208, 2008
1492008
SFINX—a drug-drug interaction database designed for clinical decision support systems
Y Böttiger, K Laine, ML Andersson, T Korhonen, B Molin, ML Ovesjö, ...
European journal of clinical pharmacology 65 (6), 627-633, 2009
1472009
A novel polymorphism in ABCB1 gene, CYP2B6* 6 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans
JK Mukonzo, D Röshammar, P Waako, M Andersson, T Fukasawa, ...
British journal of clinical pharmacology 68 (5), 690-699, 2009
1352009
Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania
M Mubi, A Janson, M Warsame, A Mårtensson, K Källander, MG Petzold, ...
PloS one 6 (7), e19753, 2011
1342011
Phenotype–genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles
C Rodríguez-Antona, JG Sayi, LL Gustafsson, L Bertilsson, ...
Biochemical and biophysical research communications 338 (1), 299-305, 2005
1312005
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ...
Expert review of clinical pharmacology 8 (1), 77-94, 2015
1272015
Policies to enhance prescribing efficiency in Europe: findings and future implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Frontiers in pharmacology 1, 141, 2011
1272011
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ...
Frontiers in pharmacology 5, 106, 2014
1222014
Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes
K Herrlin, N Yasui‐Furukori, G Tybring, J Widén, LL Gustafsson, ...
British journal of clinical pharmacology 56 (4), 415-421, 2003
1222003
The system can't perform the operation now. Try again later.
Articles 1–20